05.10.25 -- Clinical Leader Best Of April

LaShell Robinson, head of global feasibility and trial equity at Takeda, explains how the company’s Phase 3 trial for a psoriasis drug ended enrollment well before it’s goal and achieved some impressive diversity metrics. 

Discover three easy and customizable prompts to help support SOP development, refinement, and training — all areas where AI can add immediate value with minimal downside. 

Clinical Leader asked familiar voices and new faces alike: “What’s left to say, to understand, or to do with DCTs (or elements thereof) in 2025?”

Are you considering integrating AI and ML into your workflow? These six considerations will help you plan out an effective trial.

AI in clinical research serves as a "digital colleague," enhancing workflows, accelerating data analysis, and empowering study teams with precision, and insightful solutions for better patient outcomes.

Explore the pivotal role of lab-developed tests (LDTs) in medical diagnostics, their growing regulatory scrutiny, and their future trajectory in modern healthcare to advance patient care.